🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Lapdap (chlorproguanil-dapsone) is an affordable and effective drug, but pa...
Status
Completed
Location
Medical Research Council Laboratories
Start Date
2004-09
Trial ID
NCT00118794
Treatments Being Tested
Controlling malaria during pregnancy is a vital strategy in decreasing mate...
Status
Terminated
Location
Faladje Missionary Dispensary
Start Date
2005-07
Trial ID
NCT00126971
Treatments Being Tested
Pregnant women are vulnerable to malaria, with significant implications bot...
Status
Completed
Location
Muheza Designated District Hospital
Start Date
2004-01
Trial ID
NCT00146731
Treatments Being Tested
CDA is a combination of chlorproguanil, dapsone and artesunate, being devel...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-04
Trial ID
NCT00371735
Treatments Being Tested
The main objective is to compare the safety and efficacy of 4 artemisinin-b...
Status
Completed
Location
Centre Muraz/IRSS
Start Date
2007-07
Trial ID
NCT00393679
To determine whether two cheap antifolates (chlorproguanil-dapsone and sulf...
Status
Completed
Location
HealthNet International
Start Date
2004-02
Trial ID
NCT00158561
Treatments Being Tested
The purpose of the study is to see whether antimalarial drugs administered ...
Status
Completed
Location
Lwak, Abidha, Ongielo and Saradidi clinics
Start Date
2004-03
Trial ID
NCT00111163
Treatments Being Tested
Sulfadoxine-pyrimethamine (SP) is the current first-line treatment for unco...
Status
Completed
Location
Kawale Health Center
Start Date
2005-04
Trial ID
NCT00164710
Sulfadoxine-pyrimethamine is the current first-line therapy for uncomplicat...
Status
Completed
Location
Kawale Health Center
Start Date
2005-04
Trial ID
NCT00164359
Treatments Being Tested
Drug resistance to a range of antimalarial treatments has become widespread...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-06
Trial ID
NCT00519467
Treatments Being Tested